Oncology
 |
|
13 november 2018 12:00:03 |
| Addendum: Low-value approvals and high prices might incentivize ineffective drug development (Nature Clinical Practice Oncology) |
|
Tweet |
| 129 viewsCategory: Oncology |
 The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer) (BMC Cancer)A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
